JNPR
59
3
ECL
57
3
AAP
30
3
BDX
41
3
MU
39
5
TJX
43
3
SYY
45
2
VRTX
62
10
ADM
16
-9
FDX
41
11
PCAR
56
7
TRV
48
2
HUM
39
9
ROP
53
2
CHD
45
3
PYPL
41
2
KR
44
4
PWR
66
7
DIS
52
3
HAS
37
4
JNPR
59
3
ECL
57
3
AAP
30
3
BDX
41
3
MU
39
5
TJX
43
3
SYY
45
2
VRTX
62
10
ADM
16
-9
FDX
41
11
PCAR
56
7
TRV
48
2
HUM
39
9
ROP
53
2
CHD
45
3
PYPL
41
2
KR
44
4
PWR
66
7
DIS
52
3
HAS
37
4
Financhill
Back

CytoSorbents 10K Form

Sell
5

CTSO
CytoSorbents

Last Price:
0.86
Seasonality Move:
18.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q CTSO/CytoSorbents Quarterly
2023-08-01 10Q CTSO/CytoSorbents Quarterly
2023-05-02 10Q CTSO/CytoSorbents Quarterly
2022-11-03 10Q CTSO/CytoSorbents Quarterly
2022-08-02 10Q CTSO/CytoSorbents Quarterly
2022-05-03 10Q CTSO/CytoSorbents Quarterly

Receive CTSO News And Ratings

See the #1 stock for the next 7 days that we like better than CTSO

CTSO Financial Statistics

Sales & Book Value

Annual Sales: $31.08M
Cash Flow: $-4.91M
Price / Cash Flow: 0
Annual Sales: $0.31
Price / Book: 2.8

Profitability

EPS (TTM): -0.53000
Net Income (TTM): $-25.53M
Gross Margin: $17.13M
Return on Equity: -125.7%
Return on Assets: -50.3%

CytoSorbents Earnings Forecast

Key CytoSorbents Financial Ratios

  • The Gross Profit Margin over the past 16 years for CTSO is 55.10%.
  • The Selling, General & Administrative Expenses for CTSO have been equal to 121.84% of Gross Profit Margin.
  • The Research & Development expenses have been 50.60% of Revenue.
  • The Interest Expense is -15.31% of Operating Income.
  • The Net Earning history of CTSO is -91.71% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 9 years.

CytoSorbents Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: CTSO
CUSIP: 23283X
Website: cytosorbents.com

Debt

Debt-to-Equity Ratio: 0.82
Current Ratio: 2.12
Quick Ratio: 1.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CTSO Technical Analysis vs Fundamental Analysis

Sell
5
CytoSorbents (CTSO) is a Sell

Is CytoSorbents a Buy or a Sell?

  • CytoSorbents stock is rated a Sell
    The current CytoSorbents [CTSO] share price is $0.86. The Score for CTSO is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.